GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Orthocell Ltd (ASX:OCC) » Definitions » Price-to-Funds-From-Operations

Orthocell (ASX:OCC) Price-to-Funds-From-Operations : (As of Jun. 23, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Orthocell Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


Orthocell (ASX:OCC) Business Description

Industry
Traded in Other Exchanges
N/A
Address
90 South Street, Building 191, Murdoch University, Murdoch, Perth, WA, AUS, 6150
Orthocell Ltd is a regenerative medicine company. The company is engaged in the development and commercialisation of cell therapies and related technologies. Its product includes CelGro is a naturally derived collagen medical device for tissue repair and Ortho-ATI is a first-in-class cell therapy for the treatment of chronic tendon injuries.